Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$541,114
-$51,626 QoQ
Shares Held
4,283
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,336
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $8,063,885 across 15 Drug Manufacturers - General names. GILD ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,004 | $2,265,766 | |
| 2 | JNJ |
Johnson & Johnson
|
7,699 | $1,955,315 | |
| 3 | NVS |
Novartis AG
|
6,281 | $984,358 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,494 | $705,979 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
4,283 | $541,114 | |
| 6 | LLY |
ELI LILLY & Co
|
450 | $539,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,281 | $304,291 | |
| 8 | AMGN |
Amgen Inc
|
657 | $237,912 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $541,114 | 4,283 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $592,740 | 4,253 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $524,468 | 4,273 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $490,620 | 4,420 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $490,045 | 4,420 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $495,261 | 4,420 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $410,122 | 4,440 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $375,938 | 4,484 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $314,508 | 4,584 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $335,778 | 4,584 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $363,653 | 4,489 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $328,911 | 4,389 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $337,874 | 4,384 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $368,386 | 4,440 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $389,072 | 4,532 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $351,139 | 5,692 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $370,365 | 5,992 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $362,169 | 6,092 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $471,384 | 6,492 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $455,282 | 6,518 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $448,829 | 6,518 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $453,573 | 7,018 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $408,926 | 7,019 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $456,105 | 7,218 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $555,352 | 7,218 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $541,860 | 7,248 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||